Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Department of General Thoracic Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Ann Thorac Surg. 2020 Feb;109(2):420-427. doi: 10.1016/j.athoracsur.2019.09.008. Epub 2019 Oct 5.
We evaluated the prognostic impact of the presence of a ground-glass opacity (GGO) component on thin-section computed tomography for the refined clinical T classification of multiple primary lung cancers.
We reviewed 272 surgically resected, clinically node-negative multiple lung cancers. Dominant tumors were classified into 2 groups based on the presence of a GGO component; that is, a GGO tumor (consolidation tumor ratio, 0 to <1.0) or pure-solid (PS) tumor (consolidation tumor ratio, 1.0). Furthermore, multifocal GGOs (MFGGOs) were defined as lesions showing a GGO component for all tumors. Their prognoses were evaluated using Cox proportional hazard model.
There were 153 MFGGOs (56%) with a significantly better 5-year overall survival than non-MFGGOs (97.2% vs 68.5%, P < .001). A multivariable analysis revealed that MFGGO and absence of nodal involvement were independently significant prognosticators of better survival (P = .007 and P = .012, respectively). Furthermore, among the patients of non-MFGGO groups, multivariate analysis showed that a PS + PS pattern and presence of nodal involvement were independently significant prognosticators of poorer survival (P = .008 and P = .001, respectively). We divided the tumors into 3 groups based on the results and focusing on the presence of a GGO; that is, MFGGO (n = 153), PS + additional GGO (n = 81), and PS + PS (n = 38). The 5-year overall survival was clearly split among them: MFGGO, 97.2%; PS + additional GGO, 82.1%; and PS + PS, 41.3% (P < .001).
Our results suggest that presence of a GGO component has the ability to distinguish the survival even for multiple lung cancers. Further investigations including multicenter trials are certainly warranted to address the revision of T variable of multiple lung cancers considering a presence of GGO component.
我们评估了磨玻璃密度(GGO)成分在薄层 CT 中的存在对多个原发性肺癌的改良临床 T 分类的预后影响。
我们回顾了 272 例手术切除的临床淋巴结阴性的多原发性肺癌。根据 GGO 成分的存在,将优势肿瘤分为 2 组;即 GGO 肿瘤(实变肿瘤比,0 至 <1.0)或纯实性(PS)肿瘤(实变肿瘤比,1.0)。此外,多灶性 GGO(MFGGO)定义为所有肿瘤均表现出 GGO 成分的病变。使用 Cox 比例风险模型评估其预后。
有 153 例 MFGGO(56%)的 5 年总生存率显著高于非 MFGGO(97.2% vs 68.5%,P<.001)。多变量分析显示,MFGGO 和无淋巴结受累是更好生存的独立预后因素(P=0.007 和 P=0.012)。此外,在非 MFGGO 组患者中,多变量分析显示 PS+PS 模式和淋巴结受累是较差生存的独立预后因素(P=0.008 和 P=0.001)。我们根据结果将肿瘤分为 3 组,重点关注 GGO 的存在;即 MFGGO(n=153)、PS+附加 GGO(n=81)和 PS+PS(n=38)。5 年总生存率在这 3 组中明显分开:MFGGO,97.2%;PS+附加 GGO,82.1%;PS+PS,41.3%(P<.001)。
我们的结果表明,GGO 成分的存在有能力区分多个肺癌的生存情况。进一步的研究,包括多中心试验,肯定需要考虑 GGO 成分的存在,以修订多个肺癌的 T 变量。